[New therapeutic strategies for remyelination in multiple sclerosis].

This article presents an overview of approved medications with a suggested role in regeneration, regenerative treatments that are currently being tested in clinical trials, as well as promising future therapeutic approaches derived from basic glial cell research aiming at the promotion of the endogenous repair activity of the brain.
PMID: 26122637 [PubMed - as supplied by publisher]

Source: Der Nervenarzt - June 28, 2015 Category: Neurology Authors: Kremer D, Hartung HP, Stangel M, Küry P Tags: Nervenarzt Source Type: research